KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Assets By Segment AnnualBreakdown Of AssetsClinics In Active DevelopmentCost Of Revenue BreakdownDeferred RevenueEmployee StatisticsFranchise License Sold AnnualFranchise License Sold AnnuallyGross Margin %Gross ProfitNew Patients Treated AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income (Loss) By SegmentOperating Income (Loss) By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %Opex As A % Of Total Revenue %OPEX SegregationPatient Visits AnnualProperty And Equipment, Net BreakdownRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Timing Of Transfer Of ServicesRevenue By Timing Of Transfer Of Services %Revenue By Timing Of Transfer Of Services AnnualRevenue By Timing Of Transfer Of Services Annual %Total Clinics In Operation At The End Of The Period
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Joint (JYNT) Gross Profit (2013 - 2026)

Joint recorded quarterly Gross Profit of $11.1 million in Q1 2026, down 4.88% quarter-over-quarter from $11.7 million in Q4 2025, and up 9.87% year-over-year from $10.1 million in Q1 2025.

Joint's Gross Profit history runs 14 years deep, the most recent figure standing at $11.1 million for Q1 2026.

  • In Q1 2026, Gross Profit rose 9.87% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $43.3 million (up 5.68% YoY), while the FY2025 annual figure was $43.7 million, up 7.44% from the prior year.
  • Gross Profit came in at $11.1 million for Q1 2026 at Joint, down from $11.7 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $23.0 million in Q2 2022 to a low of -$25.7 million in Q4 2022.
  • A 5-year average of $10.1 million and a median of $10.1 million in 2025 frame the typical range for Gross Profit.
  • Across the five-year window, Gross Profit tumbled 230.41% in 2022 and surged 138.43% in 2023, its largest moves.
  • Joint's Gross Profit stood at -$25.7 million in 2022, then jumped by 138.43% to $9.9 million in 2023, then advanced by 16.83% to $11.5 million in 2024, then increased by 1.24% to $11.7 million in 2025, then declined by 4.88% to $11.1 million in 2026.
  • According to Business Quant data, Gross Profit over the past three periods registered $11.1 million, $11.7 million, and $10.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.